Manifold Bio

formerly Manifold Biotechnologies

Tissue-targeted medicines, designed in vivo

Cambridge, United States · Founded 2020 · $89.4M raised

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$89.4M
Last Round
$22.0M Extension RoundJan 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Manifold Bio has built the first high-throughput in vivo discovery engine, combining massively multiplexed in vivo screening and AI-powered design to create tissue-targeted biologics. The company's mDesign engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery. Manifold is growing a modular library of in vivo-optimized shuttles and a pipeline of tissue-targeted medicines, starting with brain-specific delivery.

Summary

Manifold Bio is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $89.4M in total across 4 rounds, most recently a $22.0M Extension Round in Jan 2024. Investors include KHK Fund, Triatomic Capital and Playground Global.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension Round2024 (est.)
$22.0M

Sign up to see all 4 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series DTotal funding$760.0MSep 2025
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Series CTotal funding$630.0MJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Manifold Bio on Indexed.vc
<a href="https://indexed.vc/companies/manifold-bio"><img src="https://indexed.vc/api/badge/company/manifold-bio" alt="Manifold Bio on Indexed.vc" width="260" height="76" /></a>